Literature DB >> 25142800

Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers.

Masau Sekiguchi1, Ryoji Kushima, Ichiro Oda, Haruhisa Suzuki, Hirokazu Taniguchi, Shigeki Sekine, Takeo Fukagawa, Hitoshi Katai.   

Abstract

BACKGROUND: We recently reported that the presence of a papillary adenocarcinoma (pap) component was an independent risk factor for lymphatic involvement in endoscopically resected early gastric cancer (EGC). This study aimed to investigate the potential association between the presence of a pap component in EGC and lymph node metastasis (LNM).
METHODS: In order to evaluate the association between LNM and clinicopathological features, including a pap component, we reviewed 628 surgically resected EGCs at our institution between 2009 and 2012. Clinicopathological features included age, gender, tumor location, macroscopic type, tumor size, histological type, depth, ulcerative findings, and lymphatic and venous involvement. In addition, the association between clinicopathological features and lymphatic involvement was also evaluated.
RESULTS: LNM was observed in 52 cases (8.3%). Univariate analyses revealed a significant correlation between a pap component and LNM as well as tumor size, depth, macroscopic type, a poorly differentiated adenocarcinoma component, and lymphatic and venous involvement. The percentage of positive LNM among the EGC cases with a pap component was significantly higher than in those without the component (18.2 vs. 7.3%, P = 0.010). Via multivariate analyses lymphatic involvement was identified as the strongest risk factor for LNM [odds ratio (OR) 14.1] and a pap component was revealed as an independent risk factor for lymphatic involvement (OR 3.1).
CONCLUSION: Our study revealed that EGC cases with a pap component were at higher risk of lymphatic involvement and showed a higher percentage of positive LNM. More attention should be paid to a pap component in EGC.

Entities:  

Mesh:

Year:  2014        PMID: 25142800     DOI: 10.1007/s00535-014-0991-6

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  32 in total

1.  Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa.

Authors:  R J Guo; H Arai; Y Kitayama; H Igarashi; H Hemmi; T Arai; H Hanai; H Sugimura
Journal:  Pathol Int       Date:  2001-04       Impact factor: 2.534

2.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

4.  Endoscopic mucosal resection for treatment of early gastric cancer.

Authors:  H Ono; H Kondo; T Gotoda; K Shirao; H Yamaguchi; D Saito; K Hosokawa; T Shimoda; S Yoshida
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

5.  Evaluation of lymphatic invasion in primary gastric cancer by a new monoclonal antibody, D2-40.

Authors:  Yutaka Yonemura; Yoshio Endou; Kayoko Tabachi; Taiichi Kawamura; Hyo-Yung Yun; Toru Kameya; Isamu Hayashi; Etsurou Bandou; Takuma Sasaki; Masahiro Miura
Journal:  Hum Pathol       Date:  2006-07-20       Impact factor: 3.466

6.  Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach.

Authors:  Tomio Arai; Urara Sakurai; Motoji Sawabe; Naoko Honma; Junko Aida; Yasuko Ushio; Nobuo Kanazawa; Kojiro Kuroiwa; Kaiyo Takubo
Journal:  Gastric Cancer       Date:  2012-12-29       Impact factor: 7.370

7.  Centromere numerical abnormality in the papillary, papillotubular type of early gastric cancer, a further characterization of a subset of gastric cancer.

Authors:  Jian-Ping Song; Yasuhiko Kitayama; Hisaki Igarashi; Rong-Jun Guo; You-Jie Wang; Toshihiko Kobayashi; Hiroyuki Konno; Hideki Kataoka; Masamitsu Tanaka; Haruhiko Sugimura
Journal:  Int J Oncol       Date:  2002-12       Impact factor: 5.650

8.  A multicenter retrospective study of endoscopic resection for early gastric cancer.

Authors:  Ichiro Oda; Daizo Saito; Masahiro Tada; Hiroyasu Iishi; Satoshi Tanabe; Tsuneo Oyama; Toshihiko Doi; Yoshihide Otani; Junko Fujisaki; Yoichi Ajioka; Tsutomu Hamada; Haruhiro Inoue; Takuji Gotoda; Shigeaki Yoshida
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

9.  Indication for endoscopic mucosal resection in early signet ring cell gastric cancer.

Authors:  T K Ha; J Y An; H K Youn; J H Noh; T S Sohn; S Kim
Journal:  Ann Surg Oncol       Date:  2007-12-11       Impact factor: 5.344

10.  Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer.

Authors:  T Arigami; S Natsugoe; Y Uenosono; H Arima; Y Mataki; K Ehi; S Yanagida; S Ishigami; S Hokita; T Aikou
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more
  13 in total

1.  Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe?

Authors:  Hyun Jung Lee; Gwang Ha Kim; Do Youn Park; Young Keum Kim; Hye Kyung Jeon; Bong Eun Lee; Geun Am Song
Journal:  Gastric Cancer       Date:  2017-03-07       Impact factor: 7.370

2.  Additional surgery for non-curative resection after endoscopic submucosal dissection for gastric cancer: a retrospective analysis of 200 cases.

Authors:  Hideki Sunagawa; Takahiro Kinoshita; Akio Kaito; Hidehito Shibasaki; Kazuhiro Kaneko; Atsushi Ochiai; Atsushi Ohtsu; Toshirou Nishida
Journal:  Surg Today       Date:  2016-05-18       Impact factor: 2.549

3.  Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection.

Authors:  Byung-Hoon Min; Sun-Ju Byeon; Jun Haeng Lee; Kyoung-Mee Kim; Ji Yeong An; Min Gew Choi; Jun Ho Lee; Tae Sung Sohn; Jae Moon Bae; Sung Kim
Journal:  Gastric Cancer       Date:  2017-12-26       Impact factor: 7.370

4.  Predictive factors for lymph node metastasis in early gastric cancer with lymphatic invasion after endoscopic resection.

Authors:  Ji Won Park; Sangjeong Ahn; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Kyoung-Mee Kim; Jae J Kim
Journal:  Surg Endosc       Date:  2017-04-04       Impact factor: 4.584

5.  Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins after Endoscopic Submucosal Dissection for Early Gastric Cancer.

Authors:  Tae-Se Kim; Byung-Hoon Min; Yang Won Min; Hyuk Lee; Poong-Lyul Rhee; Jae J Kim; Jun Haeng Lee
Journal:  Gut Liver       Date:  2021-09-01       Impact factor: 4.321

6.  The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy?

Authors:  Yoo Jin Lee; Jie-Hyun Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park; Jong Won Kim; Seung Ho Choi; Sung Hoon Noh
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

7.  Worse Prognosis in Papillary, Compared to Tubular, Early Gastric Carcinoma.

Authors:  Huiping Yu; Cheng Fang; Lin Chen; Jiong Shi; Xianshan Fan; Xiaoping Zou; Qin Huang
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

8.  Endoscopic Submucosal Dissection of Papillary Gastric Adenocarcinoma; Systematic Review.

Authors:  Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

9.  Predictors of lymph node metastasis and residual tumor in early gastric cancer patients after noncurative endoscopic resection: a systematic review and meta-analysis.

Authors:  Bolun Jiang; Li Zhou; Jun Lu; Yizhi Wang; Junchao Guo
Journal:  Therap Adv Gastroenterol       Date:  2020-06-23       Impact factor: 4.409

10.  Sex-specific differences in risk factors of lymph node metastasis in patients with early gastric cancer.

Authors:  Eun Sook Ryu; Seung Jun Chang; Jungsuk An; Jun-Young Yang; Jun-Won Chung; Yoon Jae Kim; Kyoung Oh Kim; Dong Kyun Park; Kwang An Kwon; Seungyoon Nam; Woon Kee Lee; Jung Ho Kim
Journal:  PLoS One       Date:  2019-10-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.